Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucidin Cream vs Vehicle for Impetigo in Paediatric Patients
NCT00986856Phase 4Terminated
- Sponsor
- LEO Pharma
- Start
- May 2004
- Primary completion
- Mar 2005
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in impetigo comparing Fucidin cream with Fucidin cream vehicle (2 arms). Primary endpoint: Number of Patients With Clinical Success (Marked Improvement or Completely Cleared) and Bacteriological Success (Eradication) at End of Treatment at Day 25. Started May 2004; status: terminated.
02
Drugs
fusidic acid
03
Conditions
impetigo
Beyond the preview
Go deeper on NCT00986856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986856.